Literature DB >> 7506762

Autosomal recessive neuromuscular disorder in a transgenic line of mice.

D Kelly1, K Chancellor, A Milatovich, U Francke, K Suzuki, B Popko.   

Abstract

We have generated a line of transgenic mice that when homozygous for the transgene develop a severe, adult-onset neuromuscular disorder. This mutation is likely the result of the insertional inactivation of an endogenous gene by the transgene integration. The mutant mice have a gait abnormality with stiffened and/or splayed hind legs, and adopt a hunched posture with some exhibiting kyphosis of the thoracic spine. These symptoms progress gradually to severe motor dysfunction. Pathologic changes were found in skeletal muscle and peripheral nerve of the mutant animals. In young mice the muscles from both upper and lower extremities show necrosis and phagocytosis. In older mice, regeneration with muscle fiber splitting, internally located nuclei, and variable fiber size are conspicuous features. Interactions between Schwann cells and axons also appear disrupted in these animals. Although many peripheral axons are well myelinated, the nerve and nerve roots contain very large bundles of juxtaposed, bare axons, reminiscent of Schwann cell-axon interactions in early development. Within these bundles there are axons large enough to be myelinated. The relationship between the pathologic changes in the muscles and nerves is not clear. The phenotypic abnormalities of these animals resemble those that occur in the spontaneous mouse mutants dystrophia muscularis and myodystrophy. Nevertheless, the chromosomal position of the transgene integration site, which was mapped by fluorescent in situ hybridization to chromosome 11, indicates that this disorder represents a new neuromuscular mutation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506762      PMCID: PMC6576840     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  4 in total

Review 1.  What do mouse models of muscular dystrophy tell us about the DAPC and its components?

Authors:  Charlotte Whitmore; Jennifer Morgan
Journal:  Int J Exp Pathol       Date:  2014-09-30       Impact factor: 1.925

2.  On the occurrence of hypomyelination in a transgenic mouse model: a consequence of the myelin basic protein promoter?

Authors:  Stefanie Gaupp; Joseph Arezzo; Dipankar J Dutta; Gareth R John; Cedric S Raine
Journal:  J Neuropathol Exp Neurol       Date:  2011-12       Impact factor: 3.685

3.  Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGE(myd) mice.

Authors:  Jessica D Gumerson; Carol S Davis; Zhyldyz T Kabaeva; John M Hayes; Susan V Brooks; Daniel E Michele
Journal:  Hum Mol Genet       Date:  2012-12-06       Impact factor: 6.150

Review 4.  The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy.

Authors:  Alec R Nickolls; Carsten G Bönnemann
Journal:  Dis Model Mech       Date:  2018-12-19       Impact factor: 5.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.